The U.S. Food and Drug Administration (FDA) has accepted an updated application asking that the dry-powder inhalation therapy…
Articles by Steve Bryson, PhD
Altavant Sciences has opened ELEVATE 2, its global Phase 2b clinical trial into the safety…
Iron replacement did not affect disease severity or the ability to function in people with…
Diminazene aceturate (DIZE), an approved antiparasitic medication, lessened the development of pulmonary arterial hypertension…
Adipose (fat) tissue may contribute to the development of pulmonary arterial hypertension (PAH)…
A gene called DNMT3BÂ was found for the first time to be a mediator of blood vessel…
Elevated blood levels of the kidney disease biomarker creatinine and the heart failure biomarker NT-proBNP were found to…
People with both pulmonary hypertension (PH) and interstitial lung disease (ILD) have worse survival outcomes than ILD patients who…
An increase in right atrial blood pressure during exercise in people with pulmonary hypertension…
Off-label use of prostacyclin therapy successfully treated five newborns with persistent pulmonary…
New variants in the DNA region that promote the activity of the BMPR2…
Elevated levels of the protein IGFBP2 were identified in the blood of people with…